Crossmark

EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection

Crossref DOI link: https://doi.org/10.1007/s40264-018-0647-1

Published Online: 2018-03-09

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Postigo, Rodrigo https://orcid.org/0000-0002-7441-9424
Brosch, Sabine

Slattery, Jim

van Haren, Anja

Dogné, Jean-Michel

Kurz, Xavier

Candore, Gianmario

Domergue, Francois

Arlett, Peter
License Information

Text and Data Mining valid from 2018-03-09
More Information

Article History

First Online: 9 March 2018

Compliance with Ethical Standards

:

: No sources of funding were received for the preparation of this review.

: Rodrigo Postigo, Sabine Brosch, Jim Slattery, Xavier Kurz, Gianmario Candore, Francois Domergue and Peter Arlett are employees of the European Medicines Agency. Jean-Michel Dogné is a member of the Pharmacovigilance Risk Assessment Committee, as well as an employee of the Federal Agency for Medicines and Health Products of Belgium. Anja van Haren is an employee of the Medicines Evaluation Board of the Netherlands and she acts as a co-chair of the EudraVigilance Expert Working Group.

: The views expressed in this article are the personal views of the authors and may not be understood or quoted as being made on behalf of or reflecting the position of the agencies or organisations with which the authors are affiliated.